Botanical species · safety record

Chaptalia nutans

The EFSA Compendium of Botanicals holds 2 constituent measurements for Chaptalia nutans. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Chaptalia nutans (L.) Polák

2Constituent measurements
0Safety records
2Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Coumarins1
  • Prunasin1

Plant parts

  • Leaves1
  • Roots and other underground parts1

Preparations

  • Solvent extraction2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CoumarinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
PrunasinLeavesSolvent extraction0.15 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Truiti, MDT., Sarragiotto, MH. Three 5-methylcoumarins from Chaptalia nutans. PHYTOCHEMISTRY, 1998, vol. 47, no. 1, p. 97-99. DOI
  2. Fikenscher, Lucie H., Hegnauer, R. Cyanogenesis in cormophytes. 12. Chaptalia nutans, a strongly cyanogenic plant of Brazil. Planta Medica, 1977, p. 266-269.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue